More tools:Markets·Screener·Research·Chat

Medtronic plc (MDT) Financial Statements

Medtronic plc
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG001S5T2S9
XNYS · usd
94.17▲ 1.07 (1.15%)
As of 2026-09-04
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close93.10
Day's Range92.31 – 94.74
52-Week Range73.31 – 106.33
Volume8.6M
Avg Volume7.4M
Share Statistics
Shares Outstanding
Employees95.0K
ExchangeXNYS
Listed1972-06-01
Share count as of August 28, 2026
Loading Income Statement…
Key questions about Medtronic plc (MDT)
What is Medtronic plc's Market Cap?
Medtronic plc's Market Cap is $120.5B, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's Enterprise Value?
Medtronic plc's Enterprise Value is $139.8B, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's Trailing P/E?
Medtronic plc's Trailing P/E is 23.0×, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's Price / Sales?
Medtronic plc's Price / Sales is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's EV / Revenue?
Medtronic plc's EV / Revenue is 3.7×, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's EV / EBITDA?
Medtronic plc's EV / EBITDA is 14.4×, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's Revenue (TTM)?
Medtronic plc's Revenue (TTM) is $37.5B, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's Net Income (TTM)?
Medtronic plc's Net Income (TTM) is $5.2B, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's EBITDA?
Medtronic plc's EBITDA is $9.7B, based on as-reported figures from SEC (XBRL) filings.
What is Medtronic plc's Diluted EPS (TTM)?
Medtronic plc's Diluted EPS (TTM) is 4.09, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJul 31, 2026Apr 24, 2026Jan 23, 2026Oct 24, 2025Jul 25, 2025Apr 25, 2025Jan 24, 2025Oct 25, 2024Jul 26, 2024Apr 26, 2024Jan 26, 2024Oct 27, 2023Jul 28, 2023Apr 28, 2023Jan 27, 2023Oct 28, 2022
Net sales
YoY growth+13.7%+9.9%+8.7%+6.6%
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets
Research and development expense
Selling, general, and administrative expense
Amortization of intangible assets
Restructuring charges, net
Certain litigation charges, net
Other operating expense (income), net
Operating profit
% of revenue18.1%19.1%16.2%18.8%
Other non-operating expense (income), net
Interest expense, net
Income before income taxes
Income tax provision
Net income
% of revenue15.2%12.8%12.8%15.4%
Net income attributable to noncontrolling interests
Net income attributable to Medtronic
% of revenue15.1%12.7%12.7%15.3%
Basic earnings per share (in dollars per share)
Diluted earnings per share (in dollars per share)